Archive

Neovasc Announces Positive Interim Results from REDUCER-I Study

NASDAQ, TSX: NVCN   VANCOUVER and MINNEAPOLIS, June 26, 2020 – Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), today announced positive interim results of the REDUCER-I study during the PCR E-Course. Stefan Verheye, M.D., PhD, ZNA Middelheim, Antwerp, Belgium presented the results of the trial during...

Read More

Neovasc Regains Compliance with Nasdaq Minimum Market Value Rule

NASDAQ, TSX: NVCN   VANCOUVER and MINNEAPOLIS, June 25, 2020 – Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), announced that it received written notification yesterday (the "Nasdaq Notice") from the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it has regained compliance with the minimum...

Read More